Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings (NUTX)
NASDAQ:NUTX
Earnings Data
Report Date
Nov 06, 2025TBA (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
1.03Last Year’s EPS
-1.72Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlights significant revenue growth, improved profitability, and strong patient satisfaction metrics. However, these positive factors are offset by concerns over delayed SEC filings, dependence on arbitration revenue, and potential litigation risks. Despite strong operational performance, the balance between highlights and lowlights suggests cautious optimism.Company Guidance
Significant Revenue Growth
Total revenue increased to $244 million for Q2 2025, a 220% increase from $76.1 million in Q2 2024. Revenue for the first half of 2025 was $455.8 million, a 217.5% increase from $143.5 million in the first half of 2024.
Improved Gross Profit and EBITDA
Gross profit was $124.8 million or 51.1% of total revenue for Q2 2025, compared to $22.6 million or 29.7% for Q2 2024. Adjusted EBITDA was $71.6 million for Q2 2025, compared to $6.8 million for the same period in 2024.
Strong Cash Flow
Net cash from operating activities was $78.2 million for the first half of 2025, compared to $16.3 million for the same period in 2024.
Patient Volume Increase
Total patient visits reached 45,573 in Q2 2025, a 10.6% increase from Q2 2024. For the first half of 2025, total patient visits were 93,842, a 15.5% increase from the first half of 2024.
High Patient Satisfaction
Maintained a patient satisfaction rate exceeding 96% across facilities in Q2 2025, complemented by high Google ratings averaging 4.7 out of 5.
Share Repurchase Program
Board of Directors authorized a stock repurchase program of up to $25 million over the next 6 months.
NUTX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NUTX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 14, 2025 | $111.13 | $92.91 | -16.40% |
May 13, 2025 | $125.93 | $158.80 | +26.10% |
Mar 31, 2025 | $47.03 | $71.40 | +51.82% |
Nov 07, 2024 | $28.89 | $31.56 | +9.24% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Clinigence Holdings (NUTX) report earnings?
Clinigence Holdings (NUTX) is schdueled to report earning on Nov 06, 2025, TBA (Confirmed).
What is Clinigence Holdings (NUTX) earnings time?
Clinigence Holdings (NUTX) earnings time is at Nov 06, 2025, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUTX EPS forecast?
NUTX EPS forecast for the fiscal quarter 2025 (Q3) is 1.03.